Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Akela Pharma Inc.
AKLPF
Healthcare
Biotechnology
"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:AKLPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Aug 28, 2012 3:50pm
RE: Someone smashing 0.04s
buyers seem more aggressive than yesterday... Bio
(0)
•••
testfreak
X
View Profile
View Bullboard History
Post by
testfreak
on Aug 28, 2012 3:47pm
Someone smashing 0.04s
Looks like someone bought 5k worth of 4s
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Aug 28, 2012 2:49pm
RE: this is undervalued fellas
Is Ingalls & Snyder manipulating the stockt? Bio
(0)
•••
testfreak
X
View Profile
View Bullboard History
Post by
testfreak
on Aug 28, 2012 2:07pm
this is undervalued fellas
this is cheap here boys n girls! strong buy company gonna break out sooner or later
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Aug 28, 2012 1:38pm
RE: RE: RE: RE: RE: Akela Pharma reports results
Ingalls & Snyder who hold 10% of shares... they set up a new sales and business development strategy. Cash flow is available on sedar... Bio
(0)
•••
Duky
X
View Profile
View Bullboard History
Comment by
Duky
on Aug 28, 2012 1:25pm
RE: RE: RE: RE: Akela Pharma reports results
Yes! Results did not seem bad (for last quarter). Exept, I noticed they did not have any info in cash flow section. Also what was private financing announcet in Feb this year? Looks positive, yet
...more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Aug 28, 2012 12:25pm
RE: RE: RE: Small share structure
The Company is continuing the reduction of its international subsidiaries with Akela Pharma Oy, the wholly owned Finnish subsidiary and Akela Pharma, Oy’s subsidiary entities, Akela Clinical Polska
...more
(0)
•••
testfreak
X
View Profile
View Bullboard History
Comment by
testfreak
on Aug 28, 2012 12:04pm
RE: RE: Small share structure
i think its just a pure waiting game, this has a tiny share structure, they have debt but are making money here! just hold accumulate and wait, if they get delisted so be it it will be on venture not
...more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Aug 28, 2012 11:20am
RE: Small share structure
Hi Testfreak! I agree with you and do not forget that we have a contract with Corcept which will be very profitable in the future...we could have a buyout in short term. Any comments on your side
...more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Aug 28, 2012 11:10am
RE: RE: RE: Akela Pharma reports results
Hi Duky, They reported for the second quarter, during the first quarter they set up a new sales and business development strategy. Bio
(0)
•••
Duky
X
View Profile
View Bullboard History
Comment by
Duky
on Aug 28, 2012 10:13am
RE: RE: Akela Pharma reports results
Did not they just report in middle of August for first half and second quater ?
(0)
•••
testfreak
X
View Profile
View Bullboard History
Post by
testfreak
on Aug 28, 2012 10:10am
Small share structure
Things will turn around here folks patience
(0)
•••
testfreak
X
View Profile
View Bullboard History
Comment by
testfreak
on Aug 28, 2012 2:21am
RE: Akela Pharma reports results
Any hope here?
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Post by
Biostocks01
on Aug 14, 2012 8:13pm
Akela Pharma reports results
AUSTIN, TX, Aug. 14, 2012/CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), an industry leader in providing contract drug formulation development as well as pharmaceutical clinical and
...more
(0)
•••
azminer
X
View Profile
View Bullboard History
Comment by
azminer
on Aug 02, 2012 3:55am
RE: three year low
Im sorry not just a three year low...a company record low...just in time for the Olympics! Sad to see though as I think AKL has worked hard to keep from this disaster but cest la vie! Such
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >